| # | Drug | Count |
|---|---|---|
| 0 | ESTRADIOL | 5 |
| 1 | ESTRADIOL GEL 0.1% | 5 |
| 2 | ESTRADIOL TRANSDERMAL | 5 |
| 3 | ESTRADIOL, | 5 |
| 4 | LEVONORGESTREL | 5 |
| 5 | APIXABAN | 3 |
| 6 | RISANKIZUMAB-RZAA | 3 |
| 7 | CONJUGATED ESTROGENS | 2 |
| 8 | ERGOCALCIFEROL | 2 |
| 9 | ESTROGENS, CONJUGATED | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SETMELANOTIDE | 1 | 0.0035 |
| 1 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 2 | SATRALIZUMAB | 1 | 0.0006 |
| 3 | TESTOSTERONE UNDECANOATE | 1 | 0.0005 |
| 4 | UBROGEPANT | 1 | 0.0002 |
| 5 | TRANEXAMIC ACID | 1 | 0.0001 |
| 6 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 1 | 0.0001 |
| 7 | ESTRADIOL TRANSDERMAL | 5 | 0.0001 |
| 8 | SELEXIPAG | 2 | 0.0001 |
| 9 | HEPARIN SODIUM | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 7 |
| 1 | Progestin [EPC] | 5 |
| 2 | Progestin-containing Intrauterine System [EPC] | 5 |
| 3 | Factor Xa Inhibitor [EPC] | 4 |
| 4 | Interleukin-23 Antagonist [EPC] | 3 |
| 5 | Corticosteroid [EPC] | 2 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 2 |
| 7 | Proton Pump Inhibitor [EPC] | 2 |
| 8 | Provitamin D2 Compound [EPC] | 2 |
| 9 | Antifibrinolytic Agent [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 5 | Progesterone [EPC] | 1 | 0.0000 |
| 6 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Estrogen [EPC] | 7 | 0.0000 |
| 8 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 9 | Interleukin-23 Antagonist [EPC] | 3 | 0.0000 |